A COMPARISON OF THE EFFICACY AND SAFETY OF COMBINED HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) AND HIGHLY PURIFIED URINARY FOLLICLE STIMULATING HORMONE (HP-UFSH) VERSUS HP-HMG ALONE FOR OVARIAN STIMULATION.

被引：1
|
作者：
Miller, C. E. [1 ]
Shapiro, D. [1 ]
Witz, C. A. [2 ]
Willey, R. [3 ]
Heiser, P. W. [3 ]
Ruman, J. [3 ]
Yankov, V. I. [3 ]
机构：
[1] Charles Miller & Associates, Naperville, IL USA
[2] Houston Fertil Inst, Houston, TX USA
[3] Ferring Pharmaceut Inc, Parsippany, NJ USA
来源：
FERTILITY AND STERILITY | 2015年 / 104卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2015.07.1008
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-631
引用
收藏
页码：E322 / E323
页数：2
相关论文
共 50 条
  • [41] Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization
    Balasch, J
    Fabregues, G
    Creus, M
    Moreno, V
    Puerto, B
    Penarrubia, J
    Carmona, F
    Vanrell, JA
    HUMAN REPRODUCTION, 1996, 11 (11) : 2400 - 2404
  • [42] HIGHLY PURIFIED HUMAN MENOTROPIN (HP-HMG) IS ASSOCIATED WITH A LOW INCIDENCE OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN PATIENTS UNDERGOING IN VITRO FERTILIZATION: MENOPUR IN GNRH ANTAGONIST SINGLE EMBRYO TRANSFER - HIGH RESPONDER (MEGASET-HR) TRIAL OUTCOMES
    Heiser, Patrick W.
    Foulk, Russell
    Seifu, Yodit
    Yankov, Vladimir
    Daftary, Gaurang S.
    FERTILITY AND STERILITY, 2018, 109 (03) : E30 - E31
  • [43] Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa (r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry
    Buehler, Klaus
    Roeder, Claudia
    Schwarze, Juan-Enrique
    Lispi, Monica
    Allignol, Arthur
    Falla, Edel
    Lukyanov, Vasily
    DHooghe, Thomas
    Fischer, Robert
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 85 : 188 - 202
  • [44] Comparing highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone in poor ovarian reserve patients undergoing intracytoplasmic sperm injection
    Korucu, D. G.
    Akgun, H.
    Tutar, M. S.
    Dogru, S.
    Gunenc, O.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2024, 89 (06): : 469 - 474
  • [45] Efficacy assessment of highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotropin during pituitary suppression in patients undergoing GIFT for unexplained infertility
    Campo, S
    Garcea, N
    GYNECOLOGICAL ENDOCRINOLOGY, 1998, 12 (03) : 161 - 166
  • [46] A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon®) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulation
    Hoomans, EHM
    Andersen, AN
    Loft, A
    Leerentveld, RA
    van Kamp, AA
    Zech, H
    HUMAN REPRODUCTION, 1999, 14 (10) : 2442 - 2447
  • [47] COST-EFFECTIVENESS ANALYSIS OF THE ORIGINATOR RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE (R-HFSH) AND URINARY HIGHLY PURIFIED MENOPAUSAL GONADOTROPIN (HMG) BASED ON DATA FROM A LARGE GERMAN REGISTRY.
    Buehler, Klaus F.
    Fischer, Robert
    Falla, Edel
    Luyten, Jeroen
    Roeder, Claudia
    Bian, Boyang
    Bilger, Wilma
    Lispi, Monica
    D'Hooghe, Thomas M.
    FERTILITY AND STERILITY, 2020, 114 (03) : E68 - E68
  • [48] A double-blind, randomized study comparing the efficacy of recombinant human follicle stimulating hormone (rhFSH/Gonal-F®) and highly purified urinary FSH (uhFSH HP/Metrodin HP®) in inducing superovulation in women undergoing assisted reproductive techniques
    Frydman, R
    Avril, C
    Camier, B
    Carles, F
    Cornet, D
    Moreau, L
    Ragage, JP
    Sage, JC
    Thebault, A
    Howles, MC
    Truong, F
    HUMAN REPRODUCTION, 1998, 13 : 94 - 94
  • [49] Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysis
    Yetkinel, Selcuk
    Aytac, Pinar caglar
    Durdag, Guelsen Dogan
    Yaginc, Didem Alkas
    Kilicdag, Esra Bulgan
    Simsek, Erhan
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (05) : 2657 - 2662
  • [50] Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone plus recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone
    Gatta, Valentina
    Tatone, Carla
    Ciriminna, Rosanna
    Vento, Marilena
    Franchi, Sara
    d'Aurora, Marco
    Sperduti, Samantha
    Cela, Vito
    Borzi, Placido
    Palermo, Roberto
    Stuppia, Liborio
    Artini, Paolo Giovanni
    FERTILITY AND STERILITY, 2013, 99 (07) : 2000 - +
12345